
Currently out of the existing stock ratings of Adam Vogel, 7 are a BUY (100%).
Analyst Adam Vogel, currently employed at CRAIG HALLUM, has had 44.44% of price targets met with an average potential upside of 73.63%, reached in 117 days on average.
Adam Vogel has documented 14 price targets and ratings displayed on 3 stocks.
Most recent stock forecast was given on MPLT, at 22-Jun-2026.
Analyst best performing recommendations are on APGE (APOGEE THERAPEUTICS).
The best stock recommendation documented was for IMNM (IMMUNOME) on 9/5/2025. The price target of $26 was fulfilled within 150 days with a profit of $15.48 (147.15%), with a performance score of 9.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-May-2024
$30
$14.31 (91.20%)
$21
11 days ago
(09-Nov-2026)
3/4 (75%)
$11.35 (60.86%)
563
Buy Since 18-Dec-2023
$35
$19.31 (123.07%)
$35
25 days ago
(27-Oct-2026)
2/11 (18.18%)
$16.23 (86.47%)
14
Buy Since 11-Feb-2026
$40
$24.31 (154.94%)
$40
2 months 11 days ago
(10-Sep-2026)
0/3 (0%)
$15.03 (60.19%)
Buy Since 02-Apr-2025
$30
$14.31 (91.20%)
$32
8 months 16 days ago
(04-Mar-2026)
1/3 (33.33%)
$9.05 (43.20%)
258
Buy Since 08-Nov-2024
$30
$10.04 (50.30%)
$33
8 months 17 days ago
(04-Mar-2026)
0/4 (0%)
$7.48 (33.21%)
Which stock is Adam Vogel most bullish on?
What Year was the first public recommendation made by Adam Vogel?